• Mashup Score: 0
    SCAI 2023 Fellows Courses | SCAI - 8 month(s) ago

    SCAI’s Fellows Courses teach future generations of interventional cardiologists the knowledge and skills they need for post-fellowship practice. If you are a current interventional cardiology fellow or are in, or have been accepted to, an advanced training program, explore which of the following four courses is the right one for you: All four courses are taught by an internationally recognized faculty in an engaging, collegial environment and scholarships are available for all fellows whose applications

    Source: scai.org
    Categories: Cardiology News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of SCAI
      SCAI

      Calling all IC Fellows—choose from 4 courses at #SCAIFellows tailored to your educational needs: ✔️#Interventional Cardiology ✔️#Congenital Heart Disease ✔️Advanced #Peripheral Vascular ✔️Advanced #Structural Heart Disease Apply for scholarship today ➡️ https://t.co/CAVvX45SeH https://t.co/IEPkYosZ2S

  • Mashup Score: 6
    LinkedIn - 8 month(s) ago

    This link will take you to a page that’s not on LinkedIn

    Source: lnkd.in
    Categories: Cardiologists, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of vonBardelebenRS
      vonBardelebenRS

      40 years of diagnostic and interventional multimodality #imaging including #echocardiography , #cardiacCT #cardiacMRI #congenital and #Structural #interventions in #cardiology at #Wiley online library scientific publications from colleagues and friends https://t.co/CUV5CcBf8U https://t.co/8dEKLGZbpd

  • Mashup Score: 2
    TRILUMINATE Illuminates at ACC.23 | SCAI - 9 month(s) ago

    At the American College of Cardiology Scientific Sessions, 2023, held in New Orleans, Drs. Sorajja and colleagues presented the 12-month results of the TRILUMINATE pivotal clinical trial (Clinical Trial to Evaluate Cardiovascular Outcomes in Patients Treated with the Tricuspid Valve Repair System Pivotal; NCT03904147). TRILUMINATE is a prospective random ized control trial comparing transcatheter edge-to-edge repair (TEER) to optimal medical therapy alone for patients with symptomatic severe tricuspid

    Source: scai.org
    Categories: Cardiology News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of SCAI
      SCAI

      Have you read about the TRILUMINATE #LateBreaking #structural trial presented at ACC.23? @mnyoung1 summarizes the findings ➡️ https://t.co/P6WGURAV8w #InterventionalCardiology #TEER #CardioTwitter https://t.co/LsSptU9a2f

  • Mashup Score: 1
    PROTECTED TAVR Misses the Mark | SCAI - 9 month(s) ago

    Stroke continues to be a feared complication of transcatheter aortic valve replacement (TAVR), affecting about 2% of patients 1. This has led to the development of numerous embolic stroke protection devices, the most widely used device being the Sentinel cerebral embolic protection (CEP) device (Boston Scientific). The SENTINEL trial, which led to FDA approval of the device, randomized 363 patients undergoing TAVR and showed that debris was captured in 99% of cases and had numerically fewer strokes but

    Source: scai.org
    Categories: Cardiology News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of SCAI
      SCAI

      #Structural news—@JaredOLearyMD offers insight into the PROTECTED TAVR trial’s shortcomings. Read more ➡️ https://t.co/M3BVaWGji8 #InterventionalCardiology #SHD #CardioTwitter https://t.co/y9W6spOIT0

  • Mashup Score: 0
    The Evolving use of Intracardiac Echocardiography in Structural Heart Disease Interventions | SCAI - 9 month(s) ago

    Structural Heart Disease Intervention (SHDI) is one of the fastest-growing medical fields. This discipline is highly predicated upon preprocedural and intraprocedural imaging. The latter has mostly meant transesophageal (TEE) imaging. However, intracardiac echocardiography (ICE) technology has rapidly accelerated and is gaining steam. Potential advantages include less patient sedation, faster workflows, and less recovery time. In the clinical arena, ICE is sometimes used in left atrial appendage occlusion

    Source: scai.org
    Categories: Cardiology News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of SCAI
      SCAI

      Potential advantages of #ICE technology for #StructuralHeartDisease Interventions include ✔️ Less patient sedation ✔️ Faster workflows ✔️ Less recovery time Read more by @OKhaliqueMD ➡️ https://t.co/9UcRrAt05U #TEE #LAAO #SHDI #Structural #CardioTwitter https://t.co/WD183rhlWU

  • Mashup Score: 0
    Scope I Trial: 3 Year Outcomes | SCAI - 9 month(s) ago

    Initially presented in 2019, the SCOPE I trial compared the Acurate Neo Self expanding valve versus the Edwards S3 balloon expandable valve in patients at intermediate to high risk for surgery with severe and symptomatic aortic stenosis via a trans-femoral approach. The study enrolled patients in a 1:1 fashion wi th a total of 739 patients (Acurate neo = 372; Edwards Sapien 3 = 367). The initial 30-day outcomes presented in 2019 showed that the Acurate neo did not meet its predefined definition for

    Source: scai.org
    Categories: Cardiology News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of SCAI
      SCAI

      Have you seen the latest results from the SCOPE I trial? Read the key takeaways from the 3-year outcomes by @FredyElSakr ➡️ https://t.co/FbucPEYH2U #structural #SHD #TAVR #InterventionalCardiology #CardioTwitter https://t.co/QvrcXFj8LL

Load More